Presentations & Posters

Collaborators:
Bio Sketches
Presentations
Publications

RRTC Projects:
Research
Training

National Database
of Educational
Resources on TBI

TBI Newsletter

Location

Links to Other Sites

Contact Us:

CENTER DIRECTOR
Walter M. High, Ph.D.
713- 666-9550

DIRECTOR OF RESEARCH
Angelle Sander, Ph.D.
713- 666-9550

DIRECTOR OF TRAINING
Karen A. Hart, Ph.D.
713-797-5946

PRESENTATIONS & POSTERS OF RRTC STAFF

2002

Boake C, McCauley SR, Levin HS, Brown SA, Goodman HS. Diagnosis of Postconcussional Disorder in Brain Injury and Extra-Cranial Trauma. Presented at the 30th annual meeting of the International Neuropsychological Society, Toronto Canada, February 2002.

Brown SA, McCauley SR, Levin HS, Boake C, Song JX. Relationship Between Gender and Psychiatric Disorders After Traumatic Brain Injury. Presented at the 30th annual meeting of the International Neuropsychological Society, Toronto Canada, February 2002.

Evans C, McCauley SR, Levin HS, Boake C, Contant CF, Song JX. Comparison of the CIQ and the GOSE as Measures of Outcome in Mild to Moderate TBI and a Matched General Trauma Sample. Presented at the 30th annual meeting of the International Neuropsychological Society, Toronto Canada, February 2002.

Francisco GE. Intrathecal Baclofen for Spastic Hypertonia. Invited presentation at HealthSouth Rehabilitation Hospital, Las Vegas NV, February 2002.

Francisco GE. Practical Approach to the Management of Spasticity. Invited presentation at the Institute for Continuing Healthcare Education, Scottsdale AZ, February 2002.

Francisco GE. Brain Injury Rehabilitation: General Concepts and Medical Complications. Presented at the 36th Annual Comprehensive Board Review course in Physical Medicine and Rehabilitation, Houston TX, March 2002.

Francisco GE. Aphasias. Presented at the 36th Annual Comprehensive Board Review course in Physical Medicine and Rehabilitation, Houston TX, March 2002.

Francisco GE. Longitudinal Effects of Intrathecal Baclofen on the Quality of Life and Function of Stroke Survivors with Spastic Hypertonia. Invited presentation at the Third World Congress of Neurorehabilitation, Venice Italy, April 2002.

Francisco GE. Chemodenervation for Focal Spastic Hypertonia Management. Presented to Austin Neurological Society, Austin TX, April 2002.

Francisco GE. Spasticity: Goal Setting. Presented at Spasticity: Innovative Management Approaches sponsored by MedSourceOne, Kansas City MO, April 2002.

Francisco GE. Reducing Disabilities and Impairments Using Intrathecal Baclofen Therapy. Presented at Spasticity: Innovative Management Approaches sponsored by MedSourceOne, Kansas City MO, April 2002.

Francisco GE. New Approaches to the Management of Spastic Hypertonia. Presented to United Cerebral Palsy Association, Dallas TX, May 2002.

Francisco GE. Recent Innovations in Spasticity Management. American Stroke Association, Pittsburgh PA, May 2002.

Francisco GE. New Techniques for Spasticity Management in Stroke. Presented at Southern Society of Physical Medicine and Rehabilitation Annual Meeting, Atlanta GA, May 2002.

Francisco GE. Advancements in Spasticity Management. Presented to Comed Communications, Henderson NV, June 2002.

Francisco GE. Intrathecal Baclofen Therapy for Cerebral Origin Spasticity. Invited presentation at the Second Congress of the Spanish Society of Neurorehabilitation, Barcelona Spain, June 2002.

High WM, Sander AM, Sherer M. Factors Impacting Outcome of Rehabilitation Following TBI. Workshop presented at the 4th Annual APA Division 22 Conference on Rehabilitation Psychology: Integrating Science, Practice and Public Policy, New Orleans LA, March 2002.

Ivanhoe CB. Everything You Ever Wanted to Know About Spasticity Management but Were Afraid to Ask. Invited presentation, sponsored by Medtronic Inc, at Rehabilitation Institute of Michigan, Detroit MI, March 2002.

Ivanhoe CB. State of the Art Spasticity Management. Invited presentation, sponsored by Medtronic Inc, at Rehabilitation Institute of Michigan, Detroit MI, March 2002

Ivanhoe CB. Intrathecal Baclofen and Treatment of Unusual Dystonias. Invited presentation, sponsored by Medtronic Neurologic/Allergan Inc, at Barrow Neurologic Institute Grand Rounds, Phoenix AZ, March 2002.

Ivanhoe CB. Intrathecal Baclofen and Botulinum Toxin Injections for Spasticity Management for Stroke and Dystonia. Invited presentation, sponsored by Medtronic Neurologic/Allergan Inc, at University of Arizona Grand Rounds, Phoenix AZ, March 2002.

Ivanhoe CB. Spasticity Management. Presented at the 36th Annual Comprehensive Board Review course in Physical Medicine and Rehabilitation, Houston TX, March 2002.

Ivanhoe CB. Intrathecal Baclofen Therapy for Dystonia: Early Observations. Invited presentation, sponsored by Medtronic Neurologic, at Medtronic Neurologic headquarters, Minneapolis MN, April 2002.

Ivanhoe CB. Management of Spastic Hypertonia of Cerebral Origin. Invited presentation to the AFRM Annual Scientific Meeting, Brisbane Australia, May 2002.

Ivanhoe CB. ITB Therapy: Case Presentations. Invited presentation to the AFRM Annual Scientific Meeting, Brisbane Australia, May 2002.

Ivanhoe CB. Pharmacological Management of Traumatic Brain Injury. Invited presentation to the AFRM Annual Scientific Meeting, Brisbane Australia, May 2002.

Ivanhoe CB. Complications of Complications: Rehabilitation of the Brain Injured Patient. Invited presentation to the BlueCross/Blue Shield Utilization Review Managers Meeting, Dallas TX, May 2002.

Kothari S. Ethical Considerations in Rehabilitation. Presented at the 36th Annual Comprehensive Board Review course in Physical Medicine and Rehabilitation, Houston TX, March 2002.

Mahoney J, Cook K, Engebretson J, Hart K, Robinson-Whelen S, Sherwood G, Sherwood AM. The Experiences of Persons with Spinal Cord Injuries Living with Spasms and Spasticity. Presented at Department of Veterans Affairs Third Annual Rehabilitation Research and Development Conference, Arlington VA, February 2002.

McCauley SR, Brown SA, Levin HS, Boake C, Contant CF, Song JX. Health-Related Quality of Life Perceptions in Patients with Postconcussional Disorder. Presented at the 30th annual meeting of the International Neuropsychological Society, Toronto Canada, February 2002.

2001

Boake C, High WM, Sander AM, Kreutzer JS, Macciocchi SN, Stringer AY, Hammond FM, Rosenthal M, Bogner JA. Effect of Blood Alcohol Level on Neuropsychological Outcome from Brain Injury. Presented at the 29th Annual Meeting of the International Neuropsychological Society, Chicago, February, 2001.

Boake C, McCauley SR, Levin HS, Song J. Postconcussional Disorder in Brain and Non-Brain Trauma: DSM-IV vs. ICD-10. Presented at the 29th Annual Meeting of the International Neuropsychological Society, Chicago, IL, February, 2001.

Brown SA, McCauley SR, Levin HS. Perceptions of Health Status Following Traumatic Brain Injury. Presented at the American Congress of Rehabilitation Medicine, Tucson AZ, October 2001.

Francisco GE. Complementary Approach to the Management of Spasticity. Presented to the Department of Physical Medicine and Rehabilitation Grand Rounds at Santa Clara Valley Medical Center, San Jose, CA, January 18, 2001.

Francisco GE. Advances in the Management of Focal Spasticity and Abnormal Muscle Activity. Presented at the Rehab Solutions Meeting, Houston, TX, February 1, 2001.

Francisco GE. Chemodenervation in the Management of Spasticity: Injection Technique and Practice Management. Presented at the Institute for Continuing Healthcare Education, San Francisco, CA, February 17, 2001.

Francisco GE. Intrathecal Baclofen Therapy for Severe Spasticity. Presented to the Amarillo Neuroscience Society, Amarillo, TX, February 20, 2001.

Francisco GE. Advances in the Management of Cerebral and Spinal Origin Spasticity. Presented at the Providence Portland Medical Center, Portland, OR, February 23, 2001.

Francisco GE. Chemodenervation in the Management of Spastsicity: Injection Technique and Practice Management. Presented at the Institute for Continuing Healthcare Education, Dallas, TX, March 10, 2001.

Francisco GE. Brain Injury Rehabilitation: General Concepts and Medical Complications. Presented at the Physical Medicine and Rehabilitation Comprehensive Review Course, Houston, TX, March 14, 2001.

Francisco GE. Chemodenervation in the Management of Spasticity: Injection Technique and Practice Management. Presented at the Institute for Continuing Healthcare Education, Atlanta, GA, March 31, 2001.

Francisco GE. New Advances in Therapies. Presented to the National Stroke Association, Houston, TX, June 18, 2001.

Francisco GE. Intrathecal Baclofen Therapy for Stroke. Presented to the Third Meeting of the North American Stroke Association, San Diego CA, August 2001.

Francisco GE. Chemodenervation for Spasticity Management. Presented to University of Arkansas Department of Physical Medicine and Rehabilitation Grand Rounds, Little Rock AR, August 2001.

Francisco GE. Neuropharmacology Topics. Presented at the Rehabilitation Solutions Conference, Houston TX, October 2001.

Francisco GE, Boake C. Improvement in Comfortable Walking Speed in Post-Stroke Spastic Hemiplegia Following Intrathecal Baclofen Therapy. Presented at the National Stroke Association meeting, San Diego CA, August 2001.

Francisco GE, Boake C. Can Response to Intrathecal Baclofen (ITB) Trial Predict Long-Term Reduction of Hypertonia Following ITB Pump Implantation? Presented at the 63rd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation, New Orleans LA, September 2001.

Francisco GE, Boake C, Silver J, Wiggs L. Team Approach to Management of Agitation. Workshop presented at the 20th Annual Symposium of the Brain Injury Association, Atlanta GA, July 2001.

Hanten G, Levin HS. Selective Learning: A Developmental Study. Presentation at the Third International Conference on Memory, Valencia Spain, July 2001.

High WM, Wefel JS, Sander AM, Boake C, Robinson K, Contant C, Hannay HJ. Comparison of the Glasgow Outcome Scale and the Disability Rating Scale as a Measure of Outcome after TBI. Presented at the 29th Annual Meeting of the International Neuropsychological Society, Chicago, IL, February 2001.

Ivanhoe CB. Spasticity Management Following Stroke: The TBI Experience. Presented at the Brownstone Restaurant sponsored by Metronic Neurological, Houston, TX, January 25, 2001.

Ivanhoe CB. Intrathecal Therapy for traumatic Brain. Presented at the Case Management Society of America Annual Spring Fling, San Jose, CA, February 9, 2001.

Ivanhoe CB. Injection Techniques for Botulinum Toxin Using Electromyography and Electrical Stimulation. Presented at the Spasticity/Case Vignettes/Anatomy Review, Los Angeles, CA, February 10, 2001.

Ivanhoe CB. Advances in the Management of Cerebral and Spinal Origin Spasticity. Presented at the Case Studies of Spasticity of Cerebral Origin, Portland, OR, February 23, 1001.

Ivanhoe CB. Spasticity Management. Presented at the Physical Medicine and Rehabilitation Comprehensive Review Course, Houston, TX, March 14, 2001.

Ivanhoe CB. Spasticity Management in Brain Injury. Presented at the Il Monello sponsored by Medtronic Neurologic, New York, NY, April 3, 2001.

Ivanhoe CB. Intrathecal Baclofen Therapy for Dystonia. Presented at the Hotel California Paris Champs-Elysees, Paris France, May 3, 2001.

Ivanhoe CB. Motor and Functional Difficulties: Intrathecal Baclofen Infusion. Presented at the International Brain Injury Association 4th World Congress on Brain Injury: Research, Innovations and Quality of Life for the New Millennium, Torino, Italy, May 7, 2001.

Ivanhoe CB. Spasticity Management for the Post Stroke Patient: New Advances in Therapies. Presented at the Management of Spasticity: The Botox Experience, Houston, TX, June 18, 2001

Ivanhoe CB. The Pharmacologic Management of Vegetative/Minimally Conscious Patients. Invited presentation Pinecrest Rehabilitation Center, Del Rey Beach FL, July 2001.

Ivanhoe CB. Early Use of Botulinum Toxin for Spasticity After Brain Injury/Workshop. Invited presentation at the Brain Injury Association 20th Annual Symposium: Building Blocks of Change, Brain Injury Rehabilitation, Research, Prevention and Policy, Atlanta GA, July 2001.

Ivanhoe CB. New Treatment Options for Spasticity Management. Invited presentation at Texas Physical Therapy Association Annual Conference/Student Conclave 2001, Arlington TX, October 2001.

Ivanhoe CB. Complications of Complications: Rehabilitation of the Severe Brain Injury Patient. Invited presentation at the Rehabilitation Solutions Conference, Houston TX, October 2001.

Ivanhoe CB. Spasticity Management. Invited presentation at University of Chicago Grand Rounds, Schwab Rehabilitation Hospital & Care Network, Chicago IL, October 2001.

Ivanhoe CB. Spasticity Management. Invited presentation at Brain Injury: The Continuum of Care Course, Mount Sinai Rehabilitation Center, New York NY, November 2001.

Ivanhoe CB. Patient Selection and Techniques of Botulinum Toxin and ITB Therapies. Invited presentation, sponsored by Allergan and Medtronic Inc, to Spasticity Evaluation and Management Program at HealthSouth Rehabilitation Institute of Tucson, Tucson AZ, December 2001.

Kothari S. Neuropharmacology. Presented at the35th Comprehensive Board Review Course in Physical Medicine and Rehabilitation, Houston, TX, March 14, 2001.

Kothari S. Assessing Competence to Make Health Care Decisions, Houston, TX, May 24, 2001.

Kothari S. Neuropharmacology. Presented at the 36th Annual Comprehensive Board Review course in Physical Medicine and Rehabilitation, Houston TX, October 2001.

Kothari S. Ethical considerations in Rehabilitation. Presented at the Rehabilitation Solutions C onference, Houston, TX, October 24, 2001.

Kothari S, Sander AM. Adjustment to brain injury: Patient and family perspectives. Workshop presented at the 19th annual meeting of the Brain Injury Association of Texas, Irving, Texas, July 2001.

McCauley SR, Levin HS, Boake C, Song J. Depression, Anxiety, and Social Support as Risk Factors for Postconcussive Disorder. Presented at the 29th Annual Meeting of the International Neuropsychological Society, Chicago, IL, February, 2001.

McCauley SR, Levin HS. Prospective Memory and Executive Function in Children with Severe Traumatic Brain Injury. Presented at the International Conference on Memory-3, Valencia Spain, July 2001.

McCauley SR, Levin HS, Boake C, Contant CF, Song JX. Health Perceptions of Patients with Postconcussional Disorder: Impact of Comorbid Psychiatric Disorders. Platform presentation at the American Congress of Rehabilitation Medicine, Tucson AZ, October 2001.

Pluth S, McCauley SR, Hannay HJ. Growth Curve Analyses: DRS and GOS Prediction of Neuropsychological Performance after CHI. Poster presented at the 29th Annual Meeting of the International Neuropsychological Society, Chicago, IL, February, 2001.

Rintala DH, Hart KA, Priebe MM. Longitudinal and Cross-Sectional Studies of Pain in Long Term Spinal Cord Injury. Presented at American Association of Spinal Cord Injury Psychologists and Social Workers, Las Vegas NV, September 2001.

Sander AM. Impact of Family functioning on Community Integration after TBI. Presented at the Annual Meeting of the International Neuropsychological Society, Chicago, IL, February, 2001.

Sander AM. Prediction of Employment Outcome after TBI from Early Neuropsychological Status. Presented at the Annual Meeting of the International Neuropsychological Society, Chicago, IL, February, 2001.

Sander AM. Effect of Blood Alcohol Level on Neuropsychological outcome from Brain Injury. Presented at the Annual Meeting of the International Neuropsychological Society, Chicago, IL, February, 2001.

Sander AM. Comparison of the Glagow Outcome Scale and the Disability Rating Scale as a Measure of Outcome after TBI. Presented at the Annual Meeting of the International Neuropsychological Society, Chicago, IL, February, 2001.

Sander AM. TIRR's NIDRR-funded Rehabilitation Research and Training Center: An overview of family response to TBI. Workshop presented at the 20th annual meeting of the Brain Injury Association, Atlanta, Georgia, July 2001.

Sander AM, Sherer M, Johnstone B et al. Neurologic and non-neurologic factors in outcome after traumatic brain injury. Presented at the 109th annual meeting of the American Psychological Association, San Francisco CA, August 2001

Scheibel RS, Pearson DA, Kotrla KJ, Bachevalier J, Faira L, Aylward E, Levin HS. Functional Magnetic Resonance Imaging of Working Memory and Inhibition After Severe Diffuse Traumatic Brain Injury. Poster presented at the 19th annual National Neurotrauma Society Symposium, San Diego CA, November 2001.

2000

Boake C, Yablon SA, Ivanhoe CB, Hammond FM, Zafonte RD. Hydrocephalus Following Traumatic Brain Injury: Incidence, Risk Factors, and Outcome. Presented at the 62nd Annual Assembly of the American Academy of Physical Medicine and Rehabilitation, San Francisco, CA, November, 2000.

Francisco GE. Update on the Management of Spasticity and Muscle Over Activity. Presented at Avera-St. Luke's Hospital, Aberdeen SD, July 10, 2000.

Francisco GE. Management of Spasticity and Abnormally Increased Tone. Presented at the Mesa Lutheran Hospital, Phoenix, AZ, August 18, 2000.

Francisco GE. Ritalin Revisited: Does it Really Work in Brain Injury Rehabilitation? Presented at the Texas Brain Injury Association 18th Annual Conference, Austin, TX, August 26, 2000.

Francisco GE. The Management of Focal Spasticity: Clinical Trends and Challenges. Presented at the Colorado Neurological Institute Lectureship Series, Englewood, CO, August 30, 2000.

Francisco GE. Management of Spasticity: Therapeutic Advances in the New Century. Presented at the HealthPartners Institute for Medical Education and Regions Hospital Rehabilitation Institute, St. Paul, MN, October 19, 2000.

Francisco GE. Emerging Therapies for Pain Management and Spasticity. Presented at the Healthsouth Rehabilitation Hospital of Midland, Odessa, TX, October 28, 2000.

Francisco GE. Botulinum Toxin Therapy for Spasticity. Presented at the National Stroke Association Meeting, Houston, TX, November 9, 2000.

Francisco GE. Traumatic Brain Injury: A Physiatrist's Perspective. Presented at the American Psychosomatic Medicine Meeting, Palm Springs, CA, November 18, 2000.

Ivanhoe CB. Treatment of Adult Spasticity with Intrathecal Baclofen Therapy. Presented at The Ripe Tomato. Sponsored by Medtronic, Inc., Fresno, California, January 27, 2000.

Ivanhoe CB. Intrathecal Baclofen Therapy of Cerebral Origin Spasticity. Presented at An Integrated Approach to Management of Spasticity of Cerebral Origin. Sponsored by John Jane Brain Injury Center of Martha Jefferson Hospital, Charlottesville, Virginia, March 17, 2000. 

Ivanhoe CB. Intrathecal Baclofen Therapy of Cerebral Origin Spasticity. Presented at An Integrated Approach to Management of Spasticity of Cerebral Origin Workshop. Sponsored by the John Jane Brain Injury Center of Martha Jefferson Hospital, Charlottesville, Virginia, March 18, 2000.

Ivanhoe CB. Patient Assessment and Injection Techniques. Presented at An Integrated Approach to Management of Spasticity of Cerebral Origin. Sponsored by the John Jane Brain Injury Center of Martha Jefferson Hospital, Charlottesville, Virginia, March 18, 2000.

Ivanhoe CB. Spasticity Management. Invited speaker by Medtronic Neurologic and Mills-Peninsula Health Services, San Francisco, California, March 30, 2000.

Ivanhoe CB. New Advances in Spasticity. Presented at the Management Faculty Orientation Meeting. Sponsored by the Professional Postgraduate Services, Philadelphia, Pennsylvania, April 1, 2000.

Ivanhoe CB. Issues in Acute Rehabilitation Following Traumatic Brain Injury. Presented at the Texas Medical Association Educational Showcase and Expo, San Antonio, Texas, May 27, 2000.

Ivanhoe CB. New Advances in Spasticity Management Presented to Saturday Seminar Series Invited Faculty sponsored by the Professional Postgraduate Services, Seattle, WA, September 9, 2000.

Ivanhoe CB. The Pharmacologic Management of Vegetative/Minimally Conscious Patients. Presented at the American Academy of Physical Medicine and Rehabilitation 62nd Annual Assembly, San Francisco, CA, November 4, 2000.

Ivanhoe CB. Intrathecal Baclofen Therapy for Spasticity Management. Presented at the Iowa Society of Rehabilitation Medicine Annual Business Meeting, Des Moines, IA, November 17, 2000.

McCauley SR, Levin HS, Boake C, Song JX. Characteristics of Subjects Lost to Follow-up in Mild/Moderate Head Injury. Poster presented at the 18th Annual Meeting of the Neurotrauma Society, New Orleans, LA, November, 2000.

Rintala DH, Novy DM, Young ME, High, WM, Chiou-Tan FY. Psychometric Properties of a Spanish Language Version of the Community Integration Questionnaire. Poster presented at the 21st Century Technology and Innovations: Advancing Rehabilitation Research and Practice 77th Annual Meeting, Hilton Head Island, SC, October 19-22, 2000.

Sander AM. Activities of the Rehabilitation and Research Training Center. Presented at the Brain Injury Association Annual Meeting, Chicago, IL, August 1, 2000.

Sander AM. Living with Traumatic Brain Injury. Presented at the 4th Annual Houston-International Community Health Summit, Houston, TX, September, 2000.

1999

Francisco GE. Innovations in Spasticity Management Following Brain Injury.  Presented at the La Segunda Conferencia Annual: Perspectivas del Texas Medical Center Para 1999, Mexico D.F., February 2, 1999.

Francisco GE. Spasticity management and movement disorders: A multidisciplinary Approach. Presented at the East Texas Medical Center Rehabilitation Center. Sponsored by Allergan Inc. and Medtronic Neurological, Tyler, Texas, February 4, 1999.

Carranza A, Zidek K, Francisco G, Graves DE. Effective Dosing of Intrathecal Baclofen in Spasticity Associated with Cerebral Palsy and Spinal Cord Injury. Poster presented at the American Academy of Physical Medicine and Rehabilitation Annual Assembly, Washington, D.C., November, 1999

Ivanhoe CB. Intrathecal Baclofen for the treatment of Spasticity of Cerebral Origin.  Presented at the Spasticity Management Seminar, University of Mississippi Medical School, Jackson, Mississippi, February 6, 1999.

Ivanhoe CB. Neuropharmacology for Brain Injury. Presented at the 33rd Comprehensive Review Course in Physical Medicine and Rehabilitation. Sponsored by Baylor College of Medicine, Houston, Texas, March 15, 1999.

Ivanhoe CB. The Intrathecal Baclofen Experience. Presented at the Spasticity Management for Post Stroke Patient: New Advances in Therapies, Houston, Texas, May 21, 1999.

Ivanhoe CB. Overview of Spasticity. Presented at the Spasticity Management for Post Stroke Patient: New Advances in Therapies, Houston, Texas, May 21, 1999.

Ivanhoe CB. Options for Spasticity Management in the Patient with Traumatic Brain Injury. Presented at the Texas Brain Injury Association Annual Meeting “Head First Into the 21st Century, Houston, Texas, August 27, 1999.

Ivanhoe CB. Team Approach to Spasticity Management. Presented at the Cerebral Origin Spasticity: Current Approaches to Management. Sponsored by the Swab Rehabilitation Hospital and Care Network and The University of Chicago, Oak Brook, Illinois, October 1, 1999.

Ivanhoe CB. The Neuroanatomy and Physiology of Spasticity. Presented at the Advances in the Treatment of Spasticity in Adults and Children. Sponsored by the Drake Center, University of Ohio and Medtronic Neurological, Inc., Cincinnati, Ohio, October 9, 1999.

Ivanhoe CB. Advanced Interventional Techniques. Presented at the Advances in the Treatment of Spasticity in Adults and Children. Sponsored by the Drake Center, University of Ohio and Medtronic Neurological, Inc., Cincinnati, Ohio, October 9, 1999.

Ivanhoe CB. Treatments for Spasticity Management. Presented at the Department of Physical Medicine and Rehabilitation Grand Rounds at the Lon Island Jewish Health System, Bay Shore, New York, November 4, 1999.

Ivanhoe CB. Brain Injury Movement Disorders: Classification and Management. Presented at the American Academy of Physical Medicine and Rehabilitation Annual Assembly, Washington, D.C., November 12, 1999.

Ivanhoe CB. Maximum Outcome for Spasticity Management from Intrathecal Baclofen Therapy. Presented at the American Academy of Physical Medicine and Rehabilitation Annual Assembly, Washington, D.C., November 12, 1999.

Ivanhoe CB. New Advances in Spasticity Management. Presented at the International Conference 1999: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins. Sponsored by Allergan, Orlando, Florida, November 19, 1999.

Sander AM. Toward an Integrated Model of Family Response to Traumatic Brain Injury: Implications for Treatment Programs. Presented at the Brain Injury Association of Texas Annual Meeting, Houston, Texas, August, 1999.

Sander AM. Family Response to Traumatic Brain Injury: Implications for Research and Treatment. Presented at the Traumatic Brain Injury in the 21st Century Conference, Bethesda, Maryland, December, 1999.

Sander AM, Robinson K, Kreutzer JS, High WM, Graves DE, Marwitz J. A Comparison of Needs, Coping Strategies, and Emotional Distress Between Family Members of Persons with Traumatic Brain Injury and Spinal Cord Injury. Pr4esented at the American Congress of Rehabilitation Medicine Annual Meeting, Orlando, Florida, October, 1999. 

1998

Francisco GE. Update on the Management of Spasticity. Presented at the University of Texas Southwestern Medical Center, Department of PM&R, Dallas, Texas, September 11, 1998.

Francisco GE. ITB Screening Trial. Presented at the Managing Severe Spasticity: A Multidisciplinary Approach. Sponsored by Medtronic Neurological, Pittsburgh, Pennsylvania, September 25-26, 1998.

Francisco GE. Cerebral Origin Spasticity—Brain Injury. Presented at the Managing Severe Spasticity: A multidisciplinary Approach. Sponsored by Medtronic Neurological, Pittsburgh, Pennsylvania, September 25-26, 1998.

Francisco GE. Spasticity Management—Injection Therapy; Nerve Blocks, Botox. Presented at the Managing Severe Spasticity: A Multidisciplinary Approach. Sponsored by Medtronic Neurological, Pittsburgh, Pennsylvania, September 25-26, 1998.

Francisco GE. The Role of Botox and Intrathecal Baclofen in Spasticity Management. Presented at the New Treatment Options for Spasticity Management. Sponsored by NMSS Lone Star Chapter, Allergan, Athena Neurosciences and Medtronic Neurological, Houston, Texas, September 29, 1998.

Francisco GE. Spasticity Management. Presented to the Texas Riviera Association of Case Managers, Corpus Christi, Texas, October 16, 1998.

Francisco GE. Expanded Considerations in the treatment of Cerebral Origin Spasticity with Intrathecal Baclofen Therapy. Presented at the Brain Injury Association 17th Annual National Symposium. Sponsored by Medtronic Neurological, New Orleans, Louisiana, October 31, 1998.

Francisco GE. Botox Injection training. Presented at the Brain Injury Association 17th Annual National Symposium. Sponsored by Allergan Inc., New Orleans, Louisiana, October 31, 1998.

High WM. Update on the National TBI Model Systems, the TBI Model System of TIRR and the RTTC on Rehabilitation Interventions Following TBI. Presented at the Brain Injury Association of Texas, Austin, Texas, August, 1998.

Ivanhoe CB. Intrathecal Baclofen Therapy for Brain Injury and Stroke.  Presented at the 4th International Neuromodulation Society Congress, Lucerne, Switzerland, September 17, 1998.

Ivanhoe, CB. Use-Dependent Exacerbation of Neuronal Injury and Functional Outcome after Focal Sensorimotor Cortical Lesions. Presented at the Neuroplasticity and Reorganization of Function after Brain Injury Conference. Sponsored by the Houston Neuropsychological Society, The Institute for Rehabilitation and Research and Baylor College of Medicine Conference, Houston, Texas, September 26, 1998.

Ivanhoe CB. Current Approaches to Management of Severe Spasticity. Presented to the Case Managers Society of America-Houston Chapter, Houston, Texas, October 14, 1998.

Contact Information:

Copyright © 2001-2002 TIRR. All rights reserved
Site developed by:

http://braininjuryresearch.org